Bryn Inc. reported its financial results for the first quarter of 2026, revealing a net loss of $30,937, compared to a net loss of $16,410 for the same period in 2025. The company's total operating expenses increased to $30,937 from $16,410 year-over-year, reflecting a significant rise in administrative expenses. As of March 31, 2026, Bryn's total assets were recorded at $2,178, while total liabilities decreased to $36,440 from $96,612 at the end of the previous fiscal year. The company's stockholders' deficit improved to $(34,263) from $(96,612) as of December 31, 2025.
In terms of operational changes, Bryn Inc. underwent a notable restructuring during the quarter. On April 24, 2026, MEDO Healthcare LLC acquired 10 million shares of the company's Series A-1 Preferred Stock from Custodian Ventures LLC for $175,000. This transaction led to the resignation of David Lazar, the previous sole director and officer, and the appointment of John Leo as the new CEO. The new management plans to rebrand the company as MEDO Technologies, Inc., focusing on acquiring pharmaceutical distributors and optimizing their operations through proprietary AI technology.
The company has not generated any revenue and remains in the process of developing a business plan. As of the latest filing, Bryn Inc. has no ongoing operations beyond maintaining corporate expenditures. The management indicated that they are exploring potential acquisitions and may require additional capital to fund these initiatives. The company is currently supported by interest-free loans from related parties, including MEDO Healthcare, which has extended $11,570 in loans during the quarter.
Bryn's financial position reflects a working capital deficit of $34,264 and an accumulated deficit of $117,593,073 as of March 31, 2026. The company has indicated that it will need to raise additional funds to support its operations and potential acquisitions. The management's outlook remains cautious, acknowledging the uncertainties surrounding capital requirements and the potential for dilution of existing shareholders if new equity or convertible debt securities are issued.
Looking ahead, Bryn Inc. anticipates continued operating losses primarily due to costs associated with regulatory compliance and the development of its business strategy. The management recognizes the challenges of establishing a viable business model and attracting qualified personnel. The company aims to address these risks by implementing a robust business and marketing strategy while navigating the complexities of the evolving pharmaceutical industry.
About Byrn, Inc.
Byrn Inc. is a dormant shell company that previously focused on healthcare data solutions and digital retail supply chain innovations. It has a history of corporate restructuring, name changes, and attempted business operations, including a UK-based acquisition that was later voided. Currently, it seeks to identify and acquire viable U.S. business opportunities through reverse mergers or asset purchases, with no ongoing operations or revenue.
About 10-Q Filings
A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.
Key points about the 10-Q:
- Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
-
Content: It includes:
- Financial statements showing the company's current financial position
- Updates from management on the performance and projections of the business
- Information about potential risks the company faces
- Details on how the company is run internally
- Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.